BACKGROUND: A novel method to quantify dyssynchrony using phase analysis of single-photon emission computed tomography (SPECT) myocardial perfusion imaging has been developed. We sought to determine the prevalence of SPECT-derived mechanical dyssynchrony, and we report clinical variables which predict mechanical dyssynchrony in patients with left ventricular dysfunction. METHODS: We used a count-based Fourier analysis method to convert the regional myocardial counts from discrete frames per cardiac cycle into a continuous thickening function which allows resolution of the phase of the onset of myocardial contraction. The standard deviation of left ventricular phases (Phase SD) describes the regional phase dispersion as a measure of dyssynchrony. Significant dyssynchrony was defined as Phase SD ≥ 43°. 260 patients with left ventricular ejection fraction ≤ 35% were examined. RESULTS: The prevalence of mechanical dyssynchrony in the entire cohort of patients studied was 52%. Univariate predictors of Phase SD were age (P = .03), black race (P = .0005), QRS duration, EF, EDV, summed stress score (SSS), and summed rest score (SRS) (all P = <.0001). Black race, male gender, QRS EF, and SRS were independent predictors of SPECT-based mechanical dyssynchrony. CONCLUSIONS: Significant SPECT-based mechanical dyssynchrony is relatively common among patients with left ventricular dysfunction. In a population of patients with predominantly ischemic heart disease referred for SPECT, a reduced EF, increasing QRS duration, severity and extent of myocardial scar on SPECT imaging are independent predictors of mechanical dyssynchrony and may serve to identify patients for dyssynchrony screening.
BACKGROUND: A novel method to quantify dyssynchrony using phase analysis of single-photon emission computed tomography (SPECT) myocardial perfusion imaging has been developed. We sought to determine the prevalence of SPECT-derived mechanical dyssynchrony, and we report clinical variables which predict mechanical dyssynchrony in patients with left ventricular dysfunction. METHODS: We used a count-based Fourier analysis method to convert the regional myocardial counts from discrete frames per cardiac cycle into a continuous thickening function which allows resolution of the phase of the onset of myocardial contraction. The standard deviation of left ventricular phases (Phase SD) describes the regional phase dispersion as a measure of dyssynchrony. Significant dyssynchrony was defined as Phase SD ≥ 43°. 260 patients with left ventricular ejection fraction ≤ 35% were examined. RESULTS: The prevalence of mechanical dyssynchrony in the entire cohort of patients studied was 52%. Univariate predictors of Phase SD were age (P = .03), black race (P = .0005), QRS duration, EF, EDV, summed stress score (SSS), and summed rest score (SRS) (all P = <.0001). Black race, male gender, QRS EF, and SRS were independent predictors of SPECT-based mechanical dyssynchrony. CONCLUSIONS: Significant SPECT-based mechanical dyssynchrony is relatively common among patients with left ventricular dysfunction. In a population of patients with predominantly ischemic heart disease referred for SPECT, a reduced EF, increasing QRS duration, severity and extent of myocardial scar on SPECT imaging are independent predictors of mechanical dyssynchrony and may serve to identify patients for dyssynchrony screening.
Authors: William T Abraham; Westby G Fisher; Andrew L Smith; David B Delurgio; Angel R Leon; Evan Loh; Dusan Z Kocovic; Milton Packer; Alfredo L Clavell; David L Hayes; Myrvin Ellestad; Robin J Trupp; Jackie Underwood; Faith Pickering; Cindy Truex; Peggy McAtee; John Messenger Journal: N Engl J Med Date: 2002-06-13 Impact factor: 91.245
Authors: F McAlister; J Ezekowitz; N Wiebe; B Rowe; C Spooner; E Crumley; L Hartling; P Kaul; G Nichol; T Klassen Journal: Evid Rep Technol Assess (Summ) Date: 2004-11
Authors: Jeroen J Bax; Theodore Abraham; S Serge Barold; Ole A Breithardt; Jeffrey W H Fung; Stephane Garrigue; John Gorcsan; David L Hayes; David A Kass; Juhani Knuuti; Christophe Leclercq; Cecilia Linde; Daniel B Mark; Mark J Monaghan; Petros Nihoyannopoulos; Martin J Schalij; Christophe Stellbrink; Cheuk-Man Yu Journal: J Am Coll Cardiol Date: 2005-12-20 Impact factor: 24.094
Authors: Ji Chen; Ernest V Garcia; Russell D Folks; C David Cooke; Tracy L Faber; E Lindsey Tauxe; Ami E Iskandrian Journal: J Nucl Cardiol Date: 2005 Nov-Dec Impact factor: 5.952
Authors: Salvador Borges-Neto; Linda K Shaw; Robert H Tuttle; John H Alexander; William T Smith; Marianna Chambless; R Edward Coleman; Robert A Harrington; Robert M Califf Journal: Am J Cardiol Date: 2005-01-15 Impact factor: 2.778
Authors: Steven L Higgins; John D Hummel; Imran K Niazi; Michael C Giudici; Seth J Worley; Leslie A Saxon; John P Boehmer; Michael B Higginbotham; Teresa De Marco; Elyse Foster; Patrick G Yong Journal: J Am Coll Cardiol Date: 2003-10-15 Impact factor: 24.094
Authors: James B Young; William T Abraham; Andrew L Smith; Angel R Leon; Randy Lieberman; Bruce Wilkoff; Robert C Canby; John S Schroeder; L Bing Liem; Shelley Hall; Kevin Wheelan Journal: JAMA Date: 2003-05-28 Impact factor: 56.272
Authors: Wael AlJaroudi; Wael A Jaber; Richard A Grimm; Thomas Marwick; Manuel D Cerqueira Journal: Int J Cardiovasc Imaging Date: 2011-10-18 Impact factor: 2.357
Authors: Wael AlJaroudi; Ji Chen; Wael A Jaber; Steven G Lloyd; Manuel D Cerqueira; Thomas Marwick Journal: Circ Cardiovasc Imaging Date: 2011-05 Impact factor: 7.792
Authors: Christopher Uebleis; Xaver Hoyer; Serge D Van Kriekinge; Franziska Schuessler; Rüdiger Paul Laubender; Alexander Becker; Sebastian Lehner; Andrei Todica; Alexander Haug; Peter Bartenstein; Paul Cumming; Guido Germano; Marcus Hacker Journal: J Nucl Cardiol Date: 2013-01-25 Impact factor: 5.952
Authors: Adam S Goldberg; M Chadi Alraies; Manuel D Cerqueira; Wael A Jaber; Wael A Aljaroudi Journal: J Nucl Cardiol Date: 2013-10-04 Impact factor: 5.952